PROCTER & GAMBLE HEALTH
Procter & Gamble Health Share Price
Procter & Gamble Health Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Procter & Gamble Health Investment Rating
-
Master Rating:
-
Procter & Gamble Health has an operating revenue of Rs. 1,103.91 Cr. on a trailing 12-month basis. An annual revenue de-growth of -28% needs improvement, Pre-tax margin of 23% is great, ROE of 25% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 66 which is a FAIR score but needs to improve its earnings, a RS Rating of 27 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 94 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
- Indicator
- Mar 2022
- Dec 2021
- Sep 2021
- Jun 2021
- Mar 2021
- Oper Rev Qtr Cr
- 268
- 278
- 273
- 285
- 219
- Operating Expenses Qtr Cr
- 199
- 216
- 195
- 237
- 188
- Operating Profit Qtr Cr
- 69
- 62
- 78
- 48
- 31
- Depreciation Qtr Cr
- 6
- 7
- 7
- 7
- 8
- Interest Qtr Cr
- 0
- 0
- 0
- 0
- 0
- Tax Qtr Cr
- 14
- 15
- 19
- 10
- 10
- Net Profit Qtr Cr
- 51
- 45
- 55
- 34
- 16
Procter & Gamble Health Technicals
EMA & SMA

- Bullish Moving Average
- ___
- 6
- Bearish Moving Average
- ___
- 10
- 20 Day
- 4363.72
- 50 Day
- 4318.73
- 100 Day
- 4390.97
- 200 Day
- 4653.85
- 20 Day
- 4371
- 50 Day
- 4256.02
- 100 Day
- 4284.97
- 200 Day
- 4651.62
Procter & Gamble Health Resistance and Support
- First Resistance
- 4420.12
- Second Resistance
- 4481.74
- Third Resistance
- 4518.47
- First Resistance
- 4321.77
- Second Resistance
- 4285.04
- Third Resistance
- 4223.42
- RSI
- 52.89
- MFI
- 57.79
- MACD Single Line
- 46.44
- MACD
- 38.47
Procter & Gamble Health Delivery and Volume
- Period
- NSE + BSE
Volume Avg - NSE + BSE
Delivery Volume Avg - NSE + BSE
Delivery Volume %
- Day
- 2,280
- 123,097
- 53.99
- Week
- 3,190
- 185,194
- 58.05
- 1 Month
- 4,960
- 286,013
- 57.66
- 6 Month
- 15,603
- 1,050,056
- 67.3
Procter & Gamble Health Result Highlights
Procter & Gamble Health Synopsis
NSE-Medical-Generic Drugs
P&G Health is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 1008.73 Cr. and Equity Capital is Rs. 16.60 Cr. for the Year ended 30/06/2021. Procter & Gamble Health Ltd. is a Public Limited Listed company incorporated on 26/04/1967 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1967PLC013726 and registration number is 013726.- Market Cap
- 7,255
- Sales
- 1,104
- Shares in Float
- 0.80
- No of funds
- 112
- Yield
- 1.86
- Book Value
- 10.32
- U/D Vol ratio
- 1.7
- LTDebt / Equity
- Alpha
- -0.09
- Beta
- 0.43
Procter & Gamble Health
- Owner Name
- Jun-22
- Mar-22
- Dec-21
- Sep-21
- Promoters
- 51.82%
- 51.82%
- 51.82%
- Mutual Funds
- 6.61%
- 6.44%
- 7.07%
- Insurance Companies
- 1.46%
- 1.46%
- 1.46%
- Foreign Portfolio Investors
- 6.47%
- 6.57%
- 5.97%
- Financial Institutions/ Banks
- Individual Investors
- 25.09%
- 24.81%
- 24.56%
- Others
- 8.55%
- 8.9%
- 9.12%
Procter & Gamble Health Management
- Name
- Designation
- Mr. Suresh Talwar
- Chairman & Ind.Director
- Mr. Milind Thatte
- Managing Director
- Mr. Amit Gupta
- Executive Director (Finance) & CFO
- Mrs. Rani Jadhav
- Independent Director
- Mr. Aalok Agrawal
- Non Executive Director
- Dr. Elizabeth Desmond
- Non Executive Director
Procter & Gamble Health Forecast
Price Estimates
Procter & Gamble Health Corporate Action
- Date
- Purpose
- Remarks
- 2022-08-29
- Audited Results & Final Dividend
- 2022-05-05
- Quarterly Results & Interim Dividend
- 2022-02-09
- Quarterly Results
- 2021-11-09
- Quarterly Results
- 2021-08-26
- Audited Results & Final Dividend
- Date
- Purpose
- Remarks
- 2022-05-13
- INTERIM
- Rs.41.00 per share(410%)Interim Dividend
Procter & Gamble Health FAQs
What is Share Price of Procter & Gamble Health ?
Procter & Gamble Health share price is ₹4375 As on 12 August, 2022 | 21:09
What is the Market Cap of Procter & Gamble Health ?
The Market Cap of Procter & Gamble Health is ₹7262.2 Cr As on 12 August, 2022 | 21:09
What is the P/E ratio of Procter & Gamble Health ?
The P/E ratio of Procter & Gamble Health is 39.2 As on 12 August, 2022 | 21:09
What is the PB ratio of Procter & Gamble Health ?
The PB ratio of Procter & Gamble Health is 10.3 As on 12 August, 2022 | 21:09